期刊文献+

生存素在慢性肝病患者外周血中的表达

Expression of serum survivin in patients with chronic hepatopathy
下载PDF
导出
摘要 目的评价慢性肝病患者外周血生存素检测对慢性肝病的诊断价值。方法将研究对象分为原发性肝癌组、乙肝肝硬化组、慢性乙型肝炎组和正常对照组。各组采集空腹外周静脉血3 ml,通过双抗体夹心酶联免疫吸附测定法检测生存素浓度。结果原发性肝癌组、乙肝肝硬化组、慢性乙型肝炎组和正常对照组外周血生存素浓度分别为(83.70±14.45)ng/L、(70.58±9.78)ng/L、(67.90±9.14)ng/L和(65.07±7.58)ng/L。慢性乙型肝炎组与正常对照组比较,差异无统计学意义(P>0.05),乙肝肝硬化组与正常对照组比较,差异有统计学意义(P<0.05),原发性肝癌组外周血生存素浓度明显高于乙肝肝硬化组、慢性乙型肝炎组和正常对照组,差异有显著统计学意义(P<0.01)。根据试验结果绘制受试者工作特征(ROC)曲线,原发性肝癌组ROC曲线下面积为0.82。结论外周血生存素是一种有诊断价值的评价慢性肝病的血清学指标,尤其对于原发性肝癌的诊断具有一定的价值。 Objective To evaluate the diagnostic value of serum survivin in patients with chronic hepatopathy. Methods Enzyme linked immunosorbent assay was used to detect the serum survivin in normal adults, patients with chronic hepatitis B, patients with hepatitis B associated liver cirrhosis and patients with primary liver cancer (PLC). Results The level of survivin in patients with PLC (83.70 ± 14.45) ng/L was significantly higher than that in patients with hepatitis B associated liver cirrhosis (70.58 ± 9.78) ng/L, chronic hepatitis B (67.90 ± 9.14) ng/L, and normal adults (65.07 ± 7.58 ) ng/L (P 〈 O. 01 ). The difference of levels of survivin in patients with hepatitis B associated liv- er cirrhosis and normal adults was significant (P 〈 O. 05 ). But the difference of the serum survivin levels in patients with hepatitis B associated liver cirrhosis and chronic hepatitis B was not significant. ROC curve was built according to the test value. The area under the curve was 0.82 (P 〈 0.01 ). Conclusion Serum survivin may be useful for diagnosis of hepatitis B associated liver cirrhosis and it can be an important diagnosis marker of PLC.
出处 《胃肠病学和肝病学杂志》 CAS 2014年第1期85-87,共3页 Chinese Journal of Gastroenterology and Hepatology
基金 2010年深圳市科技计划项目(201003021) 2011年深圳市南山区科技计划项目(2011033)
关键词 生存素 原发性肝癌 乙肝肝硬化 慢性乙型肝炎 ROC曲线 Survivin Primary liver cancer Hepatitis B associated liver cirrhosis Chronic hepatitis B ROC curve
  • 相关文献

参考文献8

  • 1Cheung CH,Cheng L,Chang KY,et al.Investigations of survivin:the past,present and future[J].Front Biosci (Landmark Ed),2011,16:952-961.
  • 2Mita AC,Mita MM,Nawrocki ST,et al.Survivin:key regulator of mitosis and apoptosis and novel target for cancer therapeutics[J].Clin Cancer Res,2008,14(16):5000-5005.
  • 3Deguchi M,Shiraki K,Inoue H,et al.Expression of survivin during liver regeneration[J].Biochem Biophys Res Commun,2002,297(1):59-64.
  • 4Fukuda S,Pelus LM.Survivin,a cancer target with an emerging role in normal adult tissues[J].Mol Cancer Ther,2006,5(5):1087-1098.
  • 5Montorsi M,Maggioni M,Falleni M,et al.Survivin gene expression in chronic liver disease and hepatocellular carcinoma[J].Hepatogastroenterology,2007,54(79):2040-2044.
  • 6Stefano JT,de Oliveira CP,Corrêa-Giannella ML,et al.Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression[J].Liver Int,2011,31(3):377-385.
  • 7徐锋,孙杰,曹文俊,李萍珠,樊绮诗.肝癌患者外周血清生存素检测的临床意义[J].检验医学,2005,20(4):353-355. 被引量:5
  • 8李剑锋,李学,赵存彦,李莹,李华琳,金瑞.原发性肝癌患者外周血生存素检测的意义[J].临床荟萃,2010,25(6):471-474. 被引量:2

二级参考文献7

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部